ACRP-PM Project Manager in Clinical Research

A clinical research project manager discovers that a study participant was enrolled without providing proper informed consent. What should be the project manager's FIRST action?

• AContinue the participant in the study while documenting the oversight
• BImmediately notify the IRB/Ethics Committee and the sponsor
• CRemove the participant from the study without notification
• DWait until the next scheduled monitoring visit to address the issue

Which document outlines the ethical principles that form the foundation for ICH GCP guidelines regarding human subject protections?

• AThe Nuremberg Code
• BThe Declaration of Helsinki
• CThe Belmont Report
• D21 CFR Part 50

A project manager is developing a recruitment plan for a Phase III oncology trial. Which strategy BEST supports ethical participant recruitment?

• AOffering substantial financial incentives to maximize enrollment speed
• BTargeting vulnerable populations who may have limited treatment options
• CEnsuring recruitment materials are reviewed and approved by the IRB/Ethics Committee befo…
• DAllowing individual sites to create their own recruitment advertisements without central…

According to ICH GCP, what is the primary purpose of a Data Safety Monitoring Board (DSMB)?

• ATo manage the trial budget and financial reporting
• BTo periodically assess participant safety data and make recommendations about trial conti…
• CTo ensure all sites are following the monitoring plan
• DTo approve the statistical analysis plan before database lock

A project manager identifies a potential conflict of interest at an investigative site where the principal investigator also holds equity in the sponsor company. What is the MOST appropriate action?

• ADisqualify the site immediately from participation
• BEnsure the conflict is disclosed and managed according to institutional and regulatory po…
• CIgnore the conflict since it does not affect data quality
• DAsk the investigator to divest their equity before the study begins

What is the minimum information that must be included in the informed consent form according to ICH E6(R3)?

• AOnly the study procedures and potential risks
• BStudy purpose, procedures, risks, benefits, alternatives, confidentiality provisions, and…
• CA brief summary of the protocol and the investigator's qualifications
• DThe sponsor's name and the total number of participants expected to enroll

A participant in a clinical trial wants to withdraw from the study. According to ICH GCP, what is the project manager's responsibility?

• AConvince the participant to remain in the study to maintain enrollment targets
• BEnsure the participant's right to withdraw is respected without penalty or loss of benefi…
• CRequire the participant to complete all remaining assessments before withdrawal
• DReport the withdrawal as a protocol deviation to the IRB

A project manager is overseeing a multinational trial and must ensure participant privacy across multiple countries. Which ICH guideline principle should guide the project manager's approach?

• AEach country's privacy laws override all ICH requirements
• BThe confidentiality of records that could identify subjects must be protected in accordan…
• CPrivacy protections only apply to electronic health records, not paper documents
• DThe sponsor may access all participant medical records without restriction for data verif…

What is the PRIMARY role of the IRB/Independent Ethics Committee (IEC) in the oversight of a clinical trial?

• ATo manage the operational aspects of the trial at each site
• BTo safeguard the rights, safety, and well-being of human subjects involved in a clinical…
• CTo negotiate the trial budget between the sponsor and investigative sites
• DTo ensure enrollment targets are met within the planned timeline

A project manager is developing a subject retention strategy for a 2-year long clinical trial. Which approach is MOST consistent with ethical principles?

• AProviding escalating financial incentives for each subsequent visit
• BImplementing patient-centric visit schedules and clear communication about study progress
• CWithholding final compensation until the participant completes the entire study
• DLimiting information about alternative treatments to discourage participant withdrawal

According to ICH GCP, which entity is ultimately responsible for the quality of trial data collected at a site?

• AThe clinical research associate (monitor)
• BThe principal investigator
• CThe sponsor's data management team
• DThe project manager

A project manager must ensure that all investigator sites maintain essential documents throughout the trial. According to ICH GCP, when must essential documents be available for inspection?

• AOnly during scheduled monitoring visits
• BOnly after the trial has been completed and the database is locked
• CBefore, during, and after the trial
• DOnly when specifically requested by a regulatory authority

Which ICH guideline provides standards for expedited reporting of adverse drug reactions during clinical trials?

• AICH E6(R3) — Good Clinical Practice
• BICH E2A — Definitions and Standards for Expedited Reporting
• CICH E9 — Statistical Principles for Clinical Trials
• DICH E8 — General Considerations for Clinical Trials

A serious adverse event (SAE) occurs at one of the trial sites. According to ICH guidelines, within what timeframe must the investigator report the SAE to the sponsor?

• AWithin 72 hours of becoming aware of the event
• BWithin 30 calendar days of the event
• CImmediately after becoming aware of it
• DWithin 7 calendar days of the event

A project manager is preparing for a regulatory authority inspection at a trial site. Which of the following is NOT typically considered an essential document that must be maintained?

• ASigned informed consent forms for all participants
• BThe investigator's brochure
• CThe project manager's personal meeting notes
• DThe site's IRB/IEC approval letter

When a protocol amendment is required during an ongoing clinical trial, what is the correct sequence of actions according to ICH GCP?

• AImplement the change immediately, then submit to the IRB/IEC for review
• BObtain sponsor approval, submit to IRB/IEC for approval, then implement at sites after ap…
• CNotify the sites first, then submit to the IRB/IEC, then obtain sponsor approval
• DSubmit to regulatory authorities first, then to the IRB/IEC, then implement at sites

According to ICH GCP, for how long must the sponsor retain essential documents after the completion or discontinuation of a clinical trial?

• AFor at least 5 years
• BIn accordance with the applicable regulatory requirements; ICH E6(R3) sets no fixed numbe…
• CFor at least 10 years
• DUntil the investigational product receives marketing authorization

What is the sponsor's obligation regarding Suspected Unexpected Serious Adverse Reactions (SUSARs) that are fatal or life-threatening?

• AReport to regulatory authorities within 30 calendar days
• BReport to regulatory authorities as soon as possible but no later than 7 calendar days af…
• CReport only to the IRB/IEC within 15 calendar days
• DReport only to the principal investigators at participating sites

A project manager is managing regulatory submissions for a new multinational trial. Which ICH guideline provides general considerations for clinical trial design?

• AICH E2A
• BICH E6(R3)
• CICH E8(R1)
• DICH E9

According to ICH GCP, when may a protocol amendment be implemented BEFORE receiving IRB/IEC approval?

• AWhen the sponsor determines the amendment is minor
• BWhen the amendment is needed to eliminate an immediate hazard to trial participants
• CWhen the majority of participating sites have agreed to the change
• DProtocol amendments may never be implemented before IRB/IEC approval

A project manager is developing the monitoring plan for a Phase II trial. According to ICH GCP, what is the PRIMARY purpose of monitoring?

• ATo ensure the trial budget stays within projected costs
• BTo verify that the rights and well-being of subjects are protected, data are accurate, an…
• CTo train site staff on proper documentation procedures
• DTo generate reports for the project steering committee

A project manager is implementing a risk-based monitoring (RBM) strategy. Which of the following BEST describes the risk-based approach to monitoring?

• AMonitoring all data points equally at every site visit
• BFocusing monitoring activities on the most critical data and processes based on identifie…
• CEliminating on-site monitoring visits entirely in favor of centralized data review
• DConducting more frequent visits to high-enrolling sites only

During a monitoring visit, a CRA discovers that source documents do not match the data entered in the electronic case report form (eCRF). What should the project manager ensure happens next?

• AThe CRA should correct the eCRF data without site involvement
• BThe site should issue a data query and correct the eCRF with proper audit trail documenta…
• CThe discrepancies should be reported to the IRB immediately
• DThe eCRF data should be accepted since it was entered by authorized site personnel

A project manager needs to establish the trial master file (TMF) for a new study. According to ICH GCP, what is the purpose of the TMF?

• ATo store only the final clinical study report
• BTo serve as a repository for essential documents that individually and collectively permi…
• CTo maintain a record of all financial transactions related to the trial
• DTo archive source documents from all participating sites

What is the primary difference between a monitoring visit report and a monitoring plan?

• AThe monitoring plan describes findings from each visit, while the report outlines the ove…
• BThe monitoring plan defines the overall monitoring strategy and procedures, while the vis…
• CThey are the same document with different names
• DThe monitoring plan is created by the IRB, while the visit report is created by the CRA

A project manager is implementing centralized monitoring for a large Phase III trial. Which activity is MOST characteristic of centralized monitoring?

• AConducting 100% source data verification at all sites
• BStatistical analysis of site-level data patterns to detect outliers and potential data qu…
• CSending monitors to every site on a monthly basis
• DRelying entirely on site self-reporting for data quality

According to ICH GCP, what must the sponsor ensure regarding the investigational product (IP) used in a clinical trial?

• AThe IP must be commercially available before the trial begins
• BThe IP is manufactured, handled, and stored in accordance with applicable GMP and used in…
• CThe IP can be distributed without labeling requirements during early phase studies
• DThe investigator is solely responsible for IP manufacturing quality

A project manager discovers that a site has been storing the investigational product at temperatures outside the specified range. What is the FIRST step in managing this situation?

• AImmediately destroy all affected product
• BQuarantine the affected product and notify the sponsor's quality team for a disposition d…
• CContinue using the product if the temperature excursion was brief
• DReplace the product without documenting the incident

In a double-blind clinical trial, who is typically authorized to break the blind (unblind) for an individual participant?

• AThe project manager at their discretion
• BOnly the regulatory authority during an inspection
• CThe investigator, when necessary for the safety management of a participant
• DThe data management team during routine data cleaning

A project manager is developing a quality management system (QMS) for a clinical trial. According to ICH E6(R3), which approach should be used?

• AFocus quality efforts only on data entry and verification
• BImplement a risk-proportionate approach focusing on activities critical to participant pr…
• CApply identical quality procedures to all trial processes regardless of risk
• DDelegate all quality management to the CRO partner

A project manager is selecting sites for a new global Phase III trial. Which factor should receive the HIGHEST priority during site selection?

• AThe site's proximity to the sponsor's headquarters
• BThe investigator's qualifications, experience, and adequate resources to conduct the trial
• CThe lowest per-patient cost among competing sites
• DThe site's willingness to accept all protocol changes without question

What is the purpose of a site initiation visit (SIV) in a clinical trial?

• ATo collect the first set of participant data
• BTo train site staff on the protocol, procedures, and regulatory requirements before enrol…
• CTo close out the site after the last participant completes the study
• DTo audit the site's financial records

According to ICH GCP, what is the sponsor's responsibility when delegating trial-related duties to a Contract Research Organization (CRO)?

• AThe sponsor transfers all responsibility to the CRO upon signing the contract
• BThe sponsor retains ultimate responsibility for the quality and integrity of the trial da…
• CThe CRO assumes full regulatory liability for the trial
• DDelegation to a CRO eliminates the need for sponsor oversight

A project manager notices that a site is consistently enrolling participants faster than expected while other sites lag behind. What should the project manager investigate FIRST?

• AThe site's marketing budget for recruitment
• BWhether the site is properly screening and applying all inclusion/exclusion criteria
• CHow to redirect resources from slower sites to this high-performing site
• DWhether to increase the site's enrollment cap immediately

Which type of monitoring visit is conducted after all participants at a site have completed the study to ensure proper documentation and IP reconciliation?

• ASite initiation visit
• BInterim monitoring visit
• CClose-out visit
• DPre-study visit

A project manager is developing the study timeline and needs to account for the critical path. In project management, what does the critical path represent?

• AThe most expensive sequence of activities in the project
• BThe longest sequence of dependent activities that determines the minimum project duration
• CThe tasks assigned to the most experienced team members
• DThe activities that can be delayed without affecting the project end date

A clinical trial project manager is creating a work breakdown structure (WBS) for a new study. What is the PRIMARY purpose of a WBS?

• ATo assign budget amounts to each team member
• BTo decompose the total scope of work into manageable deliverables and work packages
• CTo track the number of hours each team member works
• DTo create a hierarchical chart of the organization

A project manager is managing a clinical trial budget and notices that actual spending is 15% over the planned budget at the halfway point. What is the MOST appropriate action?

• AImmediately halt enrollment to reduce costs
• BPerform a variance analysis to identify the root causes and develop a corrective action p…
• CRequest a budget increase from the sponsor without analysis
• DContinue spending at the current rate and address the overrun at the end of the trial

A project manager needs to allocate resources for a multicenter trial. Which tool is MOST useful for identifying resource conflicts across multiple concurrent studies?

• AA Gantt chart showing only one study's timeline
• BA resource leveling matrix or resource management dashboard across all active studies
• CThe trial's informed consent form
• DThe investigator's brochure

A project manager discovers that a key vendor providing laboratory services has been consistently missing turnaround time targets. What should the project manager do FIRST?

• AImmediately terminate the vendor contract and find a replacement
• BReview the vendor's performance data and schedule a meeting to discuss root causes and co…
• CAccept the delays as unavoidable and adjust the project timeline
• DEscalate directly to the vendor's CEO without attempting resolution at the working level

Which of the following is the BEST example of a leading indicator for enrollment performance in a clinical trial?

• AThe total number of participants who have completed the study
• BThe screen-to-enrollment ratio and number of prescreened patients at active sites
• CThe final enrollment number at trial completion
• DThe number of protocol deviations reported to date

A project manager is developing a risk management plan for a clinical trial. What is the FIRST step in the risk management process?

• AImplementing risk mitigation strategies
• BIdentifying potential risks that could affect the trial
• CCreating a risk response budget
• DAssigning risk owners to each identified risk

In clinical trial project management, what is the difference between a risk and an issue?

• AThere is no difference; the terms are interchangeable
• BA risk is a potential future event that may impact the trial, while an issue is a current…
• CA risk only applies to safety concerns, while an issue applies to operational concerns
• DA risk is always more severe than an issue

A project manager calculates that a clinical trial has a probability of 0.3 for a risk event with a potential impact of $500,000. What is the expected monetary value (EMV) of this risk?

• A$500,000
• B$150,000
• C$350,000
• D$1,500,000

A project manager is managing a CRO responsible for data management services. The CRO has proposed changing the database platform mid-study. What should the project manager evaluate FIRST?

• AThe cost savings from switching platforms
• BThe impact on data integrity, validation requirements, and regulatory compliance
• CThe CRO's preference for the new platform
• DHow quickly the migration can be completed